Pseudotumours of the bladder are benign lesions which on clinical, radiological, and endoscopic examination appear malignant. The main hazard is unnecessarily radical surgery.
CASE HISTORY
A man aged 20 presented with an 8-week history of dysuria, frequency, suprapubic pain and one episode of frank haematuria. The patient had also noted subumbilical erythema and on examination there was a tender mass arising from the pelvis. Mid-stream urine contained trace protein, 40 red blood cells per high-power field and more than 200 white cells per high-power field; culture yielded no growth. The patient had a lymphocytosis (white cell count 16.2 x 109/L) and an erythrocyte sedimentation rate of 88/ h. All other indices were unremarkable. The clinical diagnosis was a soft-tissue tumour. Figure 1 shows the appearance on computed tomographic scanning. Examination under anaesthesia indicated that the tumour was fixed to the pubic symphysis, well circumscribed and gelatinous in nature. Tru-cut biopsies were non-diagnostic. Histological examination of chippings taken transurethrally revealed smooth muscle bundles entrapped in fibrous connective tissue which in many areas consisted of mature dense fibrocollagenous tissue but in others a more myxoid and cellular fibroblastic tissue. Scattered throughout the lesion were aggregates of chronic inflammatory cells lymphocytes, plasma cells and histiocytes with a few foci of eosinophils ( Figure 2 ). Isolated foci of neutrophils were also present. The fibroblastic process extended into the extravesical adipose tissue. No parasites or organisms were identified. There were no features of malignancy. An inflammatory pseudotumour was diagnosed.
The patient was treated for 4 months with oral antibiotics (initially ciprofloxacin 500mg twice daily, then cefadroxil 500mg twice daily). 9 months after the initial consultation the lesion had resolved both clinically and Aluminium phosphide, a cheap, easy to use, and highly effective solid fumigant pesticide, is the commonest chemical agent used for self poisoning in the state of Haryana, India, accounting for 75-80% of total poisoning deaths1. The toxic effect is due to liberation of phosphine gas on contact with water. After inhalation or absorption via the gastrointestinal tract, organ damage is widespread, but its exact pathogenesis is not clear. The damage is hypoxic in nature and is due to binding of cytochrome oxidase at the cellular level. Symptoms and signs relating to gastrointestinal, respiratory, cardiovascular, hepatobiliary, renal and central nervous system disorders have been reported2. The high mortality is due to rapid onset of shock, metabolic acidosis, cardiac arrhythmias and adult respiratory distress syndrome.The lethal dose of phosphine is 150-500mg for a 70kg person and management is conservative since there is no specific antidote.
We report here a case in which the toxic effects were complicated by intravascular haemolysis probably due to glucose-6-phosphate dehydrogenase (G-6-PD) deficiency3.
A man aged 22 presented to the emergency ward nearly 4 h after suicidal ingestion of one tablet (1 g) of aluminium phosphide. He had vomited profusely, with sweating and abdominal pain. There had been no fever, loss of consciousness, convulsions or difficulty in breathing. He denied taking any other drug or intoxicant. Four years earlier he had experienced an acute haemolytic crisis after taking primaquine and hospital investigation had revealed G-6-PD deficiency. His younger brother was likewise G-6-PD deficient.
On admission he was fully conscious and coherent, but restless and in shock with unrecordable pulse and blood pressure. His breath smelt of garlic. Gastric lavage was immediately carried out, physiological saline was infuised and he was put on a dobutamine drip along with steroids. As he had severe metabolic acidosis (pH 6.83) he was also given intravenous sodium bicarbonate. He was passing adequate amounts of urine and plasma glucose and urea and blood picture were initially normal. Blood pressure rose to 110/70 mmHg over 8 h. After 24 h he started passing high coloured urine and became mildly jaundiced; there was no bleeding from any site. The patient was haemodynamically stable but still acidotic (pH 7.12). Haemoglobinuria was present and haemoglobin was also detected in serum; serum bilirubin was 55 mmol/L, mainly unconjugated; aminotransferases were normal; and peripheral blood film showed cell fragments and 'bite cells'. All these pointed to haemolysis. Two units of fresh blood were transfused. By evening his urine output was falling and intravenous frusemide was started. Metabolic acidosis persisted (pH 7.09). Next day the jaundice deepened, with total bilirubin 77 mmol/L (still mainly unconjugated). Ultrasound of the upper abdomen was normal and serum amylase was 120 U/L. By the end of 48 h the blood pressure was again falling and the blood urea had risen to 62 mmol/L. Dobutamine infusion was resumed at a lower rate. Because
